Gilli Galore-Haskel

727 total citations
10 papers, 222 citations indexed

About

Gilli Galore-Haskel is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Gilli Galore-Haskel has authored 10 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Gilli Galore-Haskel's work include Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (2 papers) and RNA regulation and disease (2 papers). Gilli Galore-Haskel is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (2 papers) and RNA regulation and disease (2 papers). Gilli Galore-Haskel collaborates with scholars based in Israel, Italy and France. Gilli Galore-Haskel's co-authors include Michal J. Besser, Gal Markel, Jacob Schachter, Yael Laitman, Eyal Greenberg, Esther Azizi, Eitan Friedman, Camila Avivi, Iris Barshack and Rona Ortenberg and has published in prestigious journals such as European Journal of Cancer, Oncotarget and Journal of Neurology.

In The Last Decade

Gilli Galore-Haskel

10 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilli Galore-Haskel Israel 8 84 82 70 40 26 10 222
Andrew Lam United States 5 70 0.8× 50 0.6× 53 0.8× 15 0.4× 15 0.6× 13 200
Robert J. Hennessy Australia 5 67 0.8× 81 1.0× 101 1.4× 16 0.4× 7 0.3× 6 263
Marina Badenes Portugal 8 176 2.1× 80 1.0× 46 0.7× 9 0.2× 27 1.0× 14 307
María Belén Garcia-Fabiani United States 9 142 1.7× 43 0.5× 43 0.6× 24 0.6× 17 0.7× 19 267
Jarama Clucas United Kingdom 2 140 1.7× 60 0.7× 37 0.5× 45 1.1× 5 0.2× 2 246
Gifty Dominah United States 7 110 1.3× 92 1.1× 135 1.9× 24 0.6× 7 0.3× 10 326
Stephanie Newman United States 7 123 1.5× 134 1.6× 76 1.1× 39 1.0× 6 0.2× 8 316
Rubén Fernández Spain 8 116 1.4× 38 0.5× 20 0.3× 12 0.3× 11 0.4× 16 228
Abdullah H. Feroze United States 6 165 2.0× 120 1.5× 27 0.4× 9 0.2× 22 0.8× 9 320
Laura Trachsel-Moncho Spain 7 145 1.7× 26 0.3× 31 0.4× 14 0.3× 6 0.2× 10 221

Countries citing papers authored by Gilli Galore-Haskel

Since Specialization
Citations

This map shows the geographic impact of Gilli Galore-Haskel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilli Galore-Haskel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilli Galore-Haskel more than expected).

Fields of papers citing papers by Gilli Galore-Haskel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilli Galore-Haskel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilli Galore-Haskel. The network helps show where Gilli Galore-Haskel may publish in the future.

Co-authorship network of co-authors of Gilli Galore-Haskel

This figure shows the co-authorship network connecting the top 25 collaborators of Gilli Galore-Haskel. A scholar is included among the top collaborators of Gilli Galore-Haskel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilli Galore-Haskel. Gilli Galore-Haskel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Meirson, Tomer, Gilli Galore-Haskel, Ettai Markovits, et al.. (2022). Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells. Cancer Immunology Research. 10(9). 1127–1140. 8 indexed citations
2.
Galore-Haskel, Gilli, Eyal Greenberg, Inbal Yahav, et al.. (2020). microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy. Cancer Immunology Immunotherapy. 70(6). 1541–1555. 6 indexed citations
3.
Galore-Haskel, Gilli, Erez N. Baruch, Amy L. Berg, et al.. (2017). Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma. Oncotarget. 8(59). 99580–99586. 10 indexed citations
4.
Markel, Gal, Massimo Imazio, Nira Koren‐Morag, et al.. (2016). CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis. Oncotarget. 7(14). 17885–17895. 11 indexed citations
5.
Galore-Haskel, Gilli, Yael Nemlich, Eyal Greenberg, et al.. (2015). A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme. Oncotarget. 6(30). 28999–29015. 54 indexed citations
6.
Haik, Josef, Gilli Galore-Haskel, Moti Harats, et al.. (2015). Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns. Oncotarget. 7(3). 2220–2228. 7 indexed citations
7.
Ortenberg, Rona, Gilli Galore-Haskel, Sivan Sapoznik, et al.. (2014). CEACAM1 Promotes Melanoma Cell Growth through Sox-2. Neoplasia. 16(5). 451–460. 32 indexed citations
8.
Sapoznik, Sivan, Rona Ortenberg, Gilli Galore-Haskel, et al.. (2012). CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy. Cancer Immunology Immunotherapy. 61(10). 1833–1847. 39 indexed citations
9.
Galore-Haskel, Gilli, Esther Azizi, Hamida Mohamdi, et al.. (2009). MC1R variant alleles and malignant melanoma risk in Israel. European Journal of Cancer. 45(11). 2015–2022. 10 indexed citations
10.
Hassin‐Baer, Sharon, Yael Laitman, Esther Azizi, et al.. (2009). The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Journal of Neurology. 256(3). 483–487. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026